We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $8.21B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
+0.27%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$3.59B
AUM Growth
-$78.5M
Cap. Flow
-$53.5M
Cap. Flow %
-1.49%
Top 10 Hldgs %
13.47%
Holding
1,643
New
159
Increased
579
Reduced
611
Closed
173

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$52.5M
2
AFL icon
Aflac
AFL
+$24.1M
3
WLY icon
John Wiley & Sons Class A
WLY
+$18.9M
4
KMX icon
CarMax
KMX
+$17.5M
5
BIIB icon
Biogen
BIIB
+$16.9M

Sector Composition

Rank Sector Weight
1 Healthcare 15.39%
2 Energy 10.37%
3 Financials 10.35%
4 Technology 9.89%
5 Industrials 9.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MFA
676
MFA Financial
MFA
$926M
$865K 0.02%
29,250
+5,000
+21% +$157K
FEP icon
677
First Trust Europe AlphaDEX Fund
FEP
$526M
$864K 0.02%
27,921
+15,578
+126% +$501K
BRKL
678
DELISTED
Brookline Bancorp
BRKL
$861K 0.02%
76,242
-19,216
-20% -$209K
CERN
679
DELISTED
Cerner Corp
CERN
$858K 0.02%
12,420
-2,262
-15% -$158K
PRMW
680
DELISTED
Primo Water Corporation
PRMW
$851K 0.02%
+86,979
New +$832K
FTI icon
681
TechnipFMC
FTI
$28.6B
$850K 0.02%
27,525
-6,149
-18% -$189K
NUE icon
682
Nucor
NUE
$58.6B
$849K 0.02%
19,274
+6,659
+53% +$320K
CINF icon
683
Cincinnati Financial
CINF
$27.3B
$847K 0.02%
16,872
+308
+2% +$15.9K
WAB icon
684
Wabtec
WAB
$49.1B
$839K 0.02%
8,905
+58
+0.7% +$5.7K
DRE
685
DELISTED
Duke Realty Corp.
DRE
$837K 0.02%
45,100
PTCT icon
686
PTC Therapeutics
PTCT
$5.64B
$833K 0.02%
17,307
+8,387
+94% +$489K
GREK
687
Global X MSCI Greece ETF
GREK
$300M
$832K 0.02%
+27,561
New +$957K
IMOS
688
ChipMOS TECHNOLOGIES
IMOS
$1.65B
$830K 0.02%
34,486
WWAV
689
DELISTED
The WhiteWave Foods Company
WWAV
$830K 0.02%
16,984
+1,095
+7% +$51.3K
LCI
690
DELISTED
Lannett Company, Inc.
LCI
$824K 0.02%
3,467
+1,404
+68% +$337K
CP icon
691
Canadian Pacific Kansas City
CP
$78.1B
$822K 0.02%
25,640
+2,035
+9% +$72.7K
EPAC icon
692
Enerpac Tool Group
EPAC
$1.83B
$819K 0.02%
+35,488
New +$849K
TM icon
693
Toyota
TM
$224B
$819K 0.02%
6,120
-7,568
-55% -$1.04M
EL icon
694
Estee Lauder
EL
$30.4B
$811K 0.02%
9,363
-679
-7% -$58.6K
HDS
695
DELISTED
HD Supply Holdings, Inc.
HDS
$809K 0.02%
23,000
MELI icon
696
Mercado Libre
MELI
$95.2B
$808K 0.02%
+5,700
New +$807K
UTF icon
697
Cohen & Steers Infrastructure Fund
UTF
$3.11B
$806K 0.02%
38,365
-15,700
-29% -$353K
JPC icon
698
Nuveen Preferred & Income Opportunities Fund
JPC
$2.89B
$802K 0.02%
87,598
-3,165
-3% -$30.2K
FTSL icon
699
First Trust Senior Loan Fund ETF
FTSL
$2.32B
$801K 0.02%
16,389
+675
+4% +$33.3K
JAZZ icon
700
Jazz Pharmaceuticals
JAZZ
$15.9B
$800K 0.02%
4,543
-6,416
-59% -$1.15M

Similar funds

Oppenheimer & Co's Q2 2015 Portfolio in Review

As of Q2 2015, Oppenheimer & Co held 1,643 positions worth $3.59B, down 2.1% from $3.67B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Oppenheimer & Co's Q2 2015 filing shows 159 new, 579 increased, 611 reduced and 173 closed positions. Its largest new stake was Southwestern Energy Company: 251,114 shares worth $5.71M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $70.4M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 12% a quarter earlier, followed by Energy and Financials.

  • Oppenheimer & Co's largest Q2 2015 buy was Southwestern Energy Company: 251,114 shares worth $5.71M.
  • Oppenheimer & Co added most to Gilead Sciences in Q2 2015, an estimated $52.5M increase.
  • Oppenheimer & Co's biggest Q2 2015 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $70.4M.
  • Oppenheimer & Co fully exited Vanguard Total Bond Market in Q2 2015, selling an estimated $12.6M.
  • Oppenheimer & Co's ten largest holdings make up 13% of its $3.59B portfolio in Q2 2015.
  • Oppenheimer & Co opened 159 new positions and closed 173 in Q2 2015.
  • Oppenheimer & Co's portfolio value fell 2.1% quarter-over-quarter to $3.59B.

Based on Oppenheimer & Co's 13F filing for Q2 2015, filed 12 Aug 2015.